BioCentury | Nov 16, 2018
Emerging Company Profile
Virion: Harnessing viral defects
...its therapeutic interfering particles from the University of Warwick. In a PLoS One paper published in 2012, University of Warwick...
...of Tamiflu. In 2011 studies published in Vaccine and the Journal of General Virology , University of Warwick...
...Inc., South San Francisco, Calif. University of Warwick, Coventry, U.K. Virion Biotherapeutics Ltd., London, U.K. Mary Romeo, Staff Writer Abingworth University of Warwick Respiratory...
...of Tamiflu. In 2011 studies published in Vaccine and the Journal of General Virology , University of Warwick...
...Inc., South San Francisco, Calif. University of Warwick, Coventry, U.K. Virion Biotherapeutics Ltd., London, U.K. Mary Romeo, Staff Writer Abingworth University of Warwick Respiratory...